Hexagon Nutrition Ltd
Incorporated in 1993, Hexagon Nutrition
Ltd is a research-driven nutrition company.[1]
- Market Cap ₹ 789 Cr.
- Current Price ₹ 64.2
- High / Low ₹ 78.7 / 48.0
- Stock P/E 20.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 22.6 %
- ROE 18.2 %
- Face Value ₹ 1.00
Pros
Cons
- Company has a low return on equity of 13.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Fast Moving Consumer Goods Fast Moving Consumer Goods Food Products Packaged Foods
Part of Nifty IPO
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 211 | 271 | 298 | 325 | 383 | |
| 177 | 235 | 273 | 284 | 330 | |
| Operating Profit | 34 | 36 | 25 | 41 | 53 |
| OPM % | 16% | 13% | 8% | 13% | 14% |
| 6 | 5 | 7 | 6 | 12 | |
| Interest | 3 | 2 | 4 | 4 | 4 |
| Depreciation | 6 | 7 | 8 | 9 | 10 |
| Profit before tax | 31 | 32 | 20 | 34 | 51 |
| Tax % | 27% | 28% | 37% | 28% | 26% |
| 23 | 23 | 12 | 24 | 38 | |
| EPS in Rs | 2.07 | 2.11 | 1.10 | 2.20 | 3.43 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 13% |
| 3 Years: | % |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | % |
| TTM: | 58% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 13% |
| Last Year: | 18% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 |
| Reserves | 127 | 149 | 153 | 171 | 222 |
| 20 | 40 | 49 | 39 | 33 | |
| 55 | 57 | 38 | 41 | 52 | |
| Total Liabilities | 214 | 257 | 251 | 261 | 318 |
| 51 | 55 | 65 | 64 | 64 | |
| CWIP | 1 | 7 | 2 | 4 | 3 |
| Investments | 18 | 23 | 19 | 34 | 37 |
| 144 | 172 | 164 | 159 | 215 | |
| Total Assets | 214 | 257 | 251 | 261 | 318 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 29 | 11 | 23 | 38 | 6 | |
| -9 | -21 | 4 | -23 | -6 | |
| -18 | 16 | -19 | -19 | -0 | |
| Net Cash Flow | 1 | 6 | 8 | -4 | 0 |
| Free Cash Flow | 21 | -5 | 8 | 28 | -1 |
| CFO/OP | 109% | 56% | 122% | 115% | 33% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 70 | 76 | 59 | 67 | 78 |
| Inventory Days | 192 | 146 | 161 | 124 | 153 |
| Days Payable | 114 | 79 | 40 | 38 | 53 |
| Cash Conversion Cycle | 148 | 143 | 181 | 153 | 179 |
| Working Capital Days | 94 | 72 | 93 | 87 | 145 |
| ROCE % | 19% | 17% | 23% |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Branded Nutrition Segment Revenue Share % of revenue |
|
||
| Capacity Utilization - Clinical Nutrition % |
|||
| Export Revenue Share (Rest of World) % of revenue |
|||
| Number of Distributors count |
|||
| Number of Permanent Employees (Consolidated) count |
|||
| Production Volume - Dry Pre-mix MT |
|||
| Production Volume - Ready-to-Use Food (RUF/RUTF) MT |
|||
| Top 10 Customer Revenue Concentration % of revenue |
|||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Prior Intimation Of Board Meeting
- Board meets on 12 Aug 2026 to approve Q1 FY27 results, final dividend, and Articles alteration.
-
Announcement under Regulation 30 (LODR)-Credit Rating
- Hexagon Nutrition appoints CARE Ratings; assigns CARE A- Stable on ₹66 crore facilities.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- Transcript of the earnings conference call held on 17th July 2026 for audited standalone & consolidated financial results for the quarter and year ended March …
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- Audio recording of 17 July 2026 earnings call for audited FY2026 results is now available.
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - Clarification Regarding Disclosure Contained In The Red Herring Prospectus/ Prospectus
- Hexagon Nutrition clarified and corrected RHP/prospectus disclosures; no impact on issue objects, financials, operations, or shareholders.
Concalls
-
Jul 2026Transcript PPT REC
Business Profile:[1]
Hexagon Nutrition is a research-
driven nutrition company engaged
in the development, manufacturing
and marketing of nutrition products
across micronutrient premixes, branded
wellness and clinical nutrition, therapeutic formulations, ready-to-use foods (RUFs)
and micronutrient powders (MNPs).